NORML

JULY 21, 2023

“Our study provides novel information on workers’ use of cannabis for their work-related conditions, a population for which little data exist. Findings of this study demonstrate workers are turning to cannabis many months following the onset of their original work-related condition."

Data 218

Data Conditions Cannabis Sleep 218

NORML

JUNE 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 358

Patients Chronic Pain Treatment Therapy 358

NORML

DECEMBER 18, 2019

An analysis of nationwide arrest data published last year reported that New Jersey was third in the nation in total marijuana arrests and second only to Wyoming in per capita marijuana arrests. While some provisions of the new law will take immediate effect, other parts of the measure will not be enacted for 180 days.

Law 293

Law Marijuana Legislation Data 293

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 277

Clinical Trials Chronic Pain Cannabinoids Patients 277

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

JUNE 18, 2019

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.”

Patients 279

Patients Therapy Data Safety 279

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 116

Data Research and Development Patients Strains 116

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 215

Clinical Trials Chronic Pain Data Treatment 215

The Cannigma

SEPTEMBER 28, 2023

1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant.

Sleep 105

Sleep Data THC CBD 105

NORML

FEBRUARY 25, 2020

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care.

Clinical Trials 258

Clinical Trials THC Consumption Therapy 258

Cannabis Law Report

JULY 29, 2021

According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. This Data Says So appeared first on Green Market Report.

Data 116

Data Legalization Education Programs 116

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 260

Chronic Pain Therapy Patients Topical 260

NORML

JANUARY 24, 2019

.” According to nationwide survey data conducted by The American Legion in 2017, 39 percent of respondents affirmed that they “know a veteran” who is using the plant medicinally. Furthermore, twenty-two percent of respondents said they themselves “use cannabis to treat a mental or physical condition.”

Legislation 238

Legislation Chronic Pain Safety Medicine 238

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 225

Chronic Pain Patients Therapy Data 225

NORML

MARCH 20, 2019

NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events. But it is not evidence that marijuana in any way causes the condition.

THC 280

THC Data Cannabis Events 280

The Cannigma

SEPTEMBER 4, 2024

But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. And she got what she was looking for!

Data 97

Data CBD Collective Cannabinoids 97

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 185

Access Patients Chronic Pain Law 185

Canna Law Blog

MARCH 25, 2025

The conditions of the relevant licenses and permits. Data Privacy 29. What data privacy obligations do cannabis businesses have? Given the sensitive nature of medicinal cannabis information, businesses must comply with the Privacy Act 1988, including: Secure storage of patient data.

Research and Development 89

Research and Development Medicine Compliance Compliance 89

Cannabis Law Report

JULY 27, 2021

His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Schlienz and colleagues have published a paper summarizing ORR data from individuals with epilepsy in the medical journal Epilepsy & Behavior.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 81

Pharmaceutical Data Clinical Trials Research and Development 81

Project CBD

JANUARY 24, 2019

Their data suggests that ADHD causes later cannabis use, which may support the notion that THC is used to self medicate (although ADHD is associated with heavier use of many drugs). Endometriosis is a poorly-understood condition causing severe chronic pain and alterations in a woman’s menstrual cycle. Cannabis and ADHD.

Research and Development 256

Research and Development Chronic Pain Cannabinoids Treatment 256

Project CBD

JUNE 20, 2023

One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). IBD in Puerto Rico In 2016, the government of Puerto Rico legalized medicinal cannabis for a relatively short list of specific conditions, including Crohn’s disease. A flurry of recent research bears this out.

Cannabinoids 212

Cannabinoids Patients Treatment Conditions 212

NORML

AUGUST 26, 2019

The 2017 expansion of Virginia’s medical marijuana law got rid of qualifying conditions. How did getting rid of qualifying conditions make things easier for Virginia’s patients and the legislature? So, we set about these two objectives, one being to add additional conditions.

Marijuana 243

Marijuana Legalization Programs Oil 243

Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

MedicalJane

JUNE 12, 2020

All of the participants self-reported that they or their dependent patient had a diagnosed health condition at the time of the baseline assessment. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

Cannabis Law Report

MARCH 7, 2023

MSW), Chief Knowledge Officer, New Frontier Data One of the defining characteristics of state medical cannabis programs is the list of qualifying conditions. Some states like Ohio, Pennsylvania and Michigan have finite lists of qualifying conditions with additions allowed […]

State Laws 52

State Laws Data Law Conditions 52

The Cannigma

JUNE 30, 2021

In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% The most common medical conditions. In Colorado, 78.7%

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

LifeCannMD

JANUARY 2, 2024

Medical Marijuana use has shown potential benefits in managing symptoms and improving the quality of life for individuals with various health conditions. This is the reason every Medical Marijuana state lists HIV/AIDS as one of their qualifying medical conditions.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

The Cannigma

JULY 1, 2021

The data will also help doctors and researchers boost their knowledge, and assist in the creation of better alternative health products, according to People Science. For example, certain uncommon sleep conditions and mental health diagnoses with psychoses will disqualify some applicants. And there’s still a lot to know.

Sleep 116

Sleep Edibles Research and Development Data 116

Cannabis Law Report

AUGUST 23, 2021

They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic.

Patients 111

Patients Chronic Pain Marijuana Conditions 111

FloridaMarijuana.net

JUNE 27, 2018

The study’s data showed that “Cannabis significantly reduced ratings of depression, anxiety, and stress.” Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results.

Treatment 100

Treatment Marijuana Conditions Data 100

LifeCannMD

APRIL 28, 2025

For an engineer like Rick, who understood the value of evidence and data, it was a revelation. Cancer patients, folks with chronic pain, people suffering from conditions their doctors couldn’t fixthey all found their way to Rick’s door. Can it help with other conditions? Something clicked in Rick’s mind.

History 82

History Chronic Pain Research and Development Oil 82

Veriheal

DECEMBER 6, 2021

Recent data from the California Legislative Analyst Office backs Mandelman’s claim. Not to mention the unsafe working conditions that illegal markets put its employees under. . After that, Mandleman and his office are looking to work with other departments in the city to gather, and analyze cannabis sales data. And he’s right!

Data 98

Data Retail Business Legislation 98

Cannabis Law Report

JUNE 23, 2021

RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 81

CBD Data Sleep Clinical Trials 81